Back to search

Article

Clinical Virology and Effect of Vaccination and Monoclonal Antibodies against SARS-CoV-2 Omicron Sub Variant BF.7 (BA.5.2.1.7): A systematic review

2022-12-27

Abstract excerpt

Since its identification, the novel coronavirus “severe acute respiratory syndrome coronavirus 2 “(SARS-CoV-2) In in late 2019 AT Wuhan, China, by the World Health Organization (WHO), which cause the coronavirus disease 2019, is rapidly spreading, resulting in the global pandemic. As of 19 December 2022, more than 64 million confirmed cases and 6,645,812 deaths have been reported across the world. Over time, the S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7c4cd4d7-41de-5630-a4d1-202997044976
DOI
10.1101/2022.12.25.22283940
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Virology and Effect of Vaccination and Monoclonal Antibodies against SARS-CoV-2 Omicron Sub Variant BF.7 (BA.5.2.1.7): A systematic reviewDOI 10.1101/2022.12.25.22283940
Title of the article: Current Review of the SARS-CoV-2 Omicron Subvariant BF.7 (BA.5.2.1.7) Virology and Preventing Strategies.Semantic proximity
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective studySemantic proximity
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodiesSemantic proximity
BBIBP-CorV Vaccination Reduces COVID-19 Severity Rate and Accelerates Anti-Viral Antibody Responses in Heterologous Omicron InfectionSemantic proximity
Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in ChinaSemantic proximity
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalisation: a systematic review and meta-analysisSemantic proximity
Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysisSemantic proximity
SARS-CoV-2 Infections in mRNA Vaccinated Individuals are Biased for Viruses Encoding Spike E484K and Associated with Reduced Infectious Virus Loads that Correlate with Respiratory Antiviral IgG levelsSemantic proximity
Neutralization sensitivity of Omicron BA.2.75 to therapeutic monoclonal antibodiesSemantic proximity
Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2 in China: A case-control studySemantic proximity
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessSemantic proximity
Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron VariantsSemantic proximity
Select a neighboring publication to make it the new centre.